Robin Dalal

580 total citations
33 papers, 226 citations indexed

About

Robin Dalal is a scholar working on Genetics, Surgery and Epidemiology. According to data from OpenAlex, Robin Dalal has authored 33 papers receiving a total of 226 indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Genetics, 13 papers in Surgery and 11 papers in Epidemiology. Recurrent topics in Robin Dalal's work include Inflammatory Bowel Disease (22 papers), Microscopic Colitis (11 papers) and Eosinophilic Esophagitis (6 papers). Robin Dalal is often cited by papers focused on Inflammatory Bowel Disease (22 papers), Microscopic Colitis (11 papers) and Eosinophilic Esophagitis (6 papers). Robin Dalal collaborates with scholars based in United States and Canada. Robin Dalal's co-authors include David A. Schwartz, Bo Shen, Dawn B. Beaulieu, Sara Horst, Elizabeth Scoville, David T. Rubin, Baldeep Pabla, Manreet Kaur, David A. Schwartz and Lawrence S. Gaines and has published in prestigious journals such as SHILAP Revista de lepidopterología, Gastroenterology and The American Journal of Gastroenterology.

In The Last Decade

Robin Dalal

27 papers receiving 224 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Robin Dalal United States 8 145 106 67 40 26 33 226
Jonathan Blackwell United Kingdom 10 245 1.7× 181 1.7× 112 1.7× 31 0.8× 28 1.1× 23 348
Birgit Kaltz Germany 7 145 1.0× 103 1.0× 62 0.9× 14 0.3× 12 0.5× 7 199
Nienke Ipenburg Netherlands 5 280 1.9× 204 1.9× 99 1.5× 52 1.3× 50 1.9× 7 363
Rachel Grafton Australia 6 215 1.5× 157 1.5× 68 1.0× 17 0.4× 14 0.5× 17 293
Yvonne Bailey Ireland 4 176 1.2× 76 0.7× 77 1.1× 38 0.9× 10 0.4× 7 241
Henrik Stjernman Sweden 9 201 1.4× 189 1.8× 99 1.5× 15 0.4× 14 0.5× 14 301
Marcela Kreslová Czechia 5 192 1.3× 113 1.1× 94 1.4× 21 0.5× 40 1.5× 13 303
Brad Pasternak United States 6 124 0.9× 59 0.6× 104 1.6× 16 0.4× 51 2.0× 28 271
Claire Dupont France 10 117 0.8× 97 0.9× 84 1.3× 18 0.5× 27 1.0× 39 246
Luca Scarallo Italy 8 95 0.7× 83 0.8× 75 1.1× 32 0.8× 10 0.4× 34 205

Countries citing papers authored by Robin Dalal

Since Specialization
Citations

This map shows the geographic impact of Robin Dalal's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robin Dalal with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robin Dalal more than expected).

Fields of papers citing papers by Robin Dalal

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Robin Dalal. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robin Dalal. The network helps show where Robin Dalal may publish in the future.

Co-authorship network of co-authors of Robin Dalal

This figure shows the co-authorship network connecting the top 25 collaborators of Robin Dalal. A scholar is included among the top collaborators of Robin Dalal based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Robin Dalal. Robin Dalal is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Nichols, Patrick, et al.. (2024). RISANKIZUMAB DOSE ESCALATION IN PATIENTS WITH CROHN'S DISEASE. Gastroenterology. 166(3). S123–S123. 2 indexed citations
2.
Allaman, Margaret M., Dawn B. Beaulieu, Robin Dalal, et al.. (2024). NON-INVASIVE DETERMINATION OF DISEASE ACTIVITY IN CROHN’S DISEASE BY SERUM LUMINEX PROFILING. Inflammatory Bowel Diseases. 30(Supplement_1). S12–S12. 1 indexed citations
3.
Nichols, Patrick, et al.. (2024). RISANKIZUMAB DOSE ESCALATION IN PATIENTS WITH CROHN'S DISEASE. Inflammatory Bowel Diseases. 30(Supplement_1). S88–S89. 2 indexed citations
4.
Horst, Sara N., Patrick Nichols, Elizabeth Scoville, et al.. (2024). S1313 Recapturing Response and Remission With Short-Term Upadacitinib Dose Escalation. The American Journal of Gastroenterology. 119(10S). S940–S940. 1 indexed citations
5.
Shah, Nisha, James C. Slaughter, Autumn D. Zuckerman, et al.. (2023). Multicenter Study of Nonadherence to Self-Injectable Biologic Therapy in Patients With Inflammatory Bowel Disease: Risk Factors and Outcomes. SHILAP Revista de lepidopterología. 2(4). 601–607.
6.
Horst, Sara, Amy K. Motley, Sarah Campbell, et al.. (2022). S3412 Functional Medicine Approach to Care Improves Quality of Life and Blood Alcohol Levels in a Patient With Autobrewery Syndrome. The American Journal of Gastroenterology. 117(10S). e2155–e2155.
7.
Horst, Sara, Robin Dalal, Elizabeth Scoville, et al.. (2022). S858 Upadacitinib for Refractory Crohn’s Disease. The American Journal of Gastroenterology. 117(10S). e619–e620.
8.
Pabla, Baldeep, James C. Slaughter, Elizabeth Scoville, et al.. (2021). Safety and Efficacy of Vedolizumab Versus Tumor Necrosis Factor α Antagonists in an Elderly IBD Population: A Single Institution Retrospective Experience. Digestive Diseases and Sciences. 67(7). 3129–3137. 11 indexed citations
9.
Schwartz, David A., Robin Dalal, Sara Horst, et al.. (2021). Mucosal Integrity Testing Can Detect Differences in the Rectums of Patients with Inflammatory Bowel Disease Compared to Controls: A Pilot Study. Digestive Diseases and Sciences. 67(2). 639–645. 2 indexed citations
10.
Shah, Nisha, Baldeep Pabla, Elizabeth Scoville, et al.. (2021). Tofacitinib Adherence and Outcomes in Refractory Inflammatory Bowel Disease. Crohn s & Colitis 360. 3(4). otab075–otab075.
11.
Dalal, Robin, et al.. (2020). A Single Center Experience With Long-Term Ustekinumab Use and Reinduction in Patients With Refractory Crohn Disease. Crohn s & Colitis 360. 2(1). otaa013–otaa013. 12 indexed citations
12.
Kashani, Amir, Baldeep Pabla, Elizabeth Scoville, et al.. (2019). 796 Effect of Disease Location on Endoscopic and Radiographic Outcomes in Patients With Moderate to Severe Crohn's Disease Initiated on Vedolizumab. The American Journal of Gastroenterology. 114(1). S460–S461. 1 indexed citations
13.
Shah, Nisha, James C. Slaughter, Autumn D. Zuckerman, et al.. (2019). Sa1820 – Non-Adherence to Self-Injectable Biologic Medication in Patients with Moderate to Severe Inflammatory Bowel Disease is Associated with Increased Healthcare Resource Utilization. Gastroenterology. 156(6). S–414. 1 indexed citations
14.
Gaines, Lawrence S., James C. Slaughter, David A. Schwartz, et al.. (2019). Does Reverse Causality Underlie the Temporal Relationship Between Depression and Crohn’s Disease?. Inflammatory Bowel Diseases. 26(3). 423–428. 5 indexed citations
15.
Slaughter, James C., Amy K. Motley, Dawn W. Adams, et al.. (2018). Mo1877 - Adalimumab Short Term Dose Intensification with Microreinduction in Patients with Crohn's Disease Allows for Long Term Medication Persistence. Gastroenterology. 154(6). S–835. 1 indexed citations
16.
Dalal, Robin, Bo Shen, & David A. Schwartz. (2018). Management of Pouchitis and Other Common Complications of the Pouch. Inflammatory Bowel Diseases. 24(5). 989–996. 49 indexed citations
17.
Dalal, Robin, et al.. (2018). Ustekinumab Reinduction for Loss of Response or Interruption of Treatment. The American Journal of Gastroenterology. 113(Supplement). S377–S378. 1 indexed citations
18.
Dalal, Robin, et al.. (2017). Depressive Symptoms Predict Anti-tumor Necrosis Factor Therapy Noncompliance in Patients with Inflammatory Bowel Disease. Digestive Diseases and Sciences. 62(12). 3563–3567. 21 indexed citations
19.
Mahmoud, Najjia N., Sandra de Montbrun, Puja Shah, et al.. (2017). Current management of perianal Crohn’s disease. Current Problems in Surgery. 54(5). 262–298. 7 indexed citations
20.
Dalal, Robin & David A. Schwartz. (2016). The Gastroenterologist’s Role in Management of Perianal Fistula. Gastrointestinal Endoscopy Clinics of North America. 26(4). 693–705. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jonathan Blackwell Breakdown of academic impact, for papers by Birgit Kaltz Breakdown of academic impact, for papers by Nienke Ipenburg Breakdown of academic impact, for papers by Rachel Grafton Breakdown of academic impact, for papers by Yvonne Bailey Breakdown of academic impact, for papers by Henrik Stjernman Breakdown of academic impact, for papers by Marcela Kreslová Breakdown of academic impact, for papers by Brad Pasternak Breakdown of academic impact, for papers by Claire Dupont Breakdown of academic impact, for papers by Luca Scarallo
Rankless by CCL
2026